Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-45
Closed -$6.1K 855
2024
Q2
$6.1K Hold
45
﹤0.01% 689
2024
Q1
$5.82K Buy
+45
New +$5.44K ﹤0.01% 702
2023
Q4
Sell
-45
Closed -$4.1K 823
2023
Q3
$4.1K Hold
45
﹤0.01% 707
2023
Q2
$5K Hold
45
﹤0.01% 691
2023
Q1
$5K Hold
45
﹤0.01% 693
2022
Q4
$5K Hold
45
﹤0.01% 657
2022
Q3
$4K Hold
45
﹤0.01% 724
2022
Q2
$4K Hold
45
﹤0.01% 734
2022
Q1
$4K Hold
45
﹤0.01% 777
2021
Q4
$5K Hold
45
﹤0.01% 761
2021
Q3
$6K Hold
45
﹤0.01% 711
2021
Q2
$6K Hold
45
﹤0.01% 716
2021
Q1
$5K Hold
45
﹤0.01% 750
2020
Q4
$5K Hold
45
﹤0.01% 701
2020
Q3
$4K Hold
45
﹤0.01% 742
2020
Q2
$3K Hold
45
﹤0.01% 798
2020
Q1
$3K Hold
45
﹤0.01% 770
2019
Q4
$4K Hold
45
﹤0.01% 685
2019
Q3
$4K Hold
45
﹤0.01% 682
2019
Q2
$4K Hold
45
﹤0.01% 685
2019
Q1
$4K Hold
45
﹤0.01% 677
2018
Q4
$3K Hold
45
﹤0.01% 733
2018
Q3
$3K Hold
45
﹤0.01% 737
2018
Q2
$3K Hold
45
﹤0.01% 788
2018
Q1
$3K Hold
45
﹤0.01% 736
2017
Q4
$3K Buy
+45
New +$2.99K ﹤0.01% 636

Other funds holding XYL

Front Row Advisors's XYL Position: Q3 2024 in Review

Front Row Advisors sold out of Xylem (XYL) in Q3 2024, closing a stake of 45 shares — an estimated $6.1K sold.

Front Row Advisors first reported a position in XYL in Q4 2017 and held it in 26 quarters. The position peaked at $6.1K in Q2 2024. 1,018 funds tracked by Wall St. Rank hold XYL as of Q3 2024.

  • Front Row Advisors reported no remaining Xylem position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 45 Xylem shares in Q3 2024, an estimated $6.1K.
  • Front Row Advisors first reported a position in Xylem in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Xylem position peaked at $6.1K in Q2 2024.
  • 1,018 funds tracked by Wall St. Rank held Xylem as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.